Your session is about to expire
← Back to Search
Human Amnion Membrane Allograft for Prostate Cancer Recovery (HAMMER Trial)
HAMMER Trial Summary
This trial looks at if a membrane can help men recover from prostate surgery faster by improving erectile function and urinary control.
HAMMER Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.HAMMER Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have had radiation therapy to my pelvic area before.I use pads due to urinary leakage.My EPIC26 score is below 60.I have received treatment for prostate cancer before.I use non-oral aids for erectile dysfunction.I am unable to make my own medical decisions.I am a man aged 40-80 with localized prostate cancer planning a specific surgery at UM.
- Group 1: Membrane Arm: dHACM Group
- Group 2: Control Arm: No dHACM Group
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is recruitment for this experiment still open?
"Data on clinicaltrials.gov reveals that this trial, first posted June 30th 2023 and most recently updated April 24th 2023, is no longer recruiting participants at this time. Fortunately, there are 887 other medical studies actively seeking volunteers presently."
Is there an age cap for individuals wishing to participate in this research?
"Individuals 40 years of age and older, but younger than 80 are being sought for enrollment in this study."
Could you please elaborate on the potential perils of Membrane Arm: dHACM Group to patients?
"Our team's assessment of the safety profile of Membrane Arm: dHACM Group is a 2, which implies that there exists some evidence supporting its safety but not any data indicating its efficacy."
Could I participate in this research endeavor?
"In order to qualify for this trial, prostate cancer patients aged 40-80 are welcome. The total number of participants is expected to reach 240 individuals."
Share this study with friends
Copy Link
Messenger